NAT10 and neoplasm: Multivariable analysis identified HALP (HR = 0.384, 95% CI: 0.225-0.655), LMR (HR = 0.483, 95% CI: 0.286-0.815), tumor stage (HR = 2.435, 95% CI: 1.432-4.140), and chemotherapy cycles (HR = 0.380, 95% CI: 0.223-0.647) as independent predictors of DFS.